gpi0100 and aluminum-phosphate

gpi0100 has been researched along with aluminum-phosphate* in 1 studies

Other Studies

1 other study(ies) available for gpi0100 and aluminum-phosphate

ArticleYear
Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalis.
    Vaccine, 2003, Oct-01, Volume: 21, Issue:27-30

    The gram-negative, anaerobic bacterium Porphyromonas gingivalis, has been implicated in the etiology of adult periodontal disease. Among the potential virulence factors of this bacterium, the non-fimbrial adhesin hemagglutinin B (HagB) appears to be involved in the initial adherence of the bacteria to host tissue and the induction of anti-HagB antibody responses affords some protection from experimental alveolar bone loss. In the present study, we have investigated the ability of the quillaja saponin derivative GPI-0100 to act as an immunostimulant of responses to HagB following subcutaneous (s.c.) or intranasal (i.n.) immunization of mice. We have also compared the immunopotentiating ability of GPI-0100 with that of five other adjuvants. Evidence is provided that GPI-0100 was more effective than monophosphoryl lipid A and alum in inducing serum anti-HagB responses following s.c. immunization. A comparison of the responses induced following i.n. immunization with HagB and adjuvant revealed that the heat-labile toxin of Escherichia coli (LT) and the non-enzymatic mutant LT (E112K), followed by GPI-0100 potentiated higher serum and mucosal anti-HagB antibody responses, which in most cases were higher than those seen with the other adjuvants tested (i.e. monophosphoryl lipid A, alum and the B subunit of cholera toxin). Furthermore, a difference was seen in the nature of the serum IgG anti-HagB response based on the adjuvant used and route of immunization. These results demonstrate the effectiveness of GPI-0100 as both a systemic and mucosal adjuvant and support its potential use in the development of vaccines against periodontal, as well as other pathogens.

    Topics: Adhesins, Bacterial; Adjuvants, Immunologic; Administration, Intranasal; Aluminum Compounds; Animals; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Cholera Toxin; Female; Hemagglutinins; Immunity, Mucosal; Immunoglobulin A; Immunoglobulin G; Injections, Subcutaneous; Lectins; Lipid A; Mice; Mice, Inbred BALB C; Mucous Membrane; Phosphates; Porphyromonas gingivalis; Quillaja; Recombinant Proteins; Saliva; Saponins; Vagina

2003